Literature DB >> 29935376

Cytokine modulation of atopic itch.

Anna M Trier1, Brian S Kim2.   

Abstract

Atopic dermatitis (AD) is an inflammatory skin disease characterized by two primary features: relapsing skin lesions and chronic itch. Major advances in our understanding of type 2 immunity have led to new insights into the critical factors that promote the development and persistence of AD-associated skin inflammation. Although inflammation is strongly associated with the development of atopic itch, the precise mechanisms by which itch arises in AD are poorly understood. In this review, we highlight recent studies that have started to unveil how various proinflammatory factors released within the skin can elicit sensations of itch and discuss the therapeutic potential of targeting these neuroimmunologic processes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29935376      PMCID: PMC8811732          DOI: 10.1016/j.coi.2018.05.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  38 in total

1.  Basophils promote innate lymphoid cell responses in inflamed skin.

Authors:  Brian S Kim; Kelvin Wang; Mark C Siracusa; Steven A Saenz; Jonathan R Brestoff; Laurel A Monticelli; Mario Noti; Elia D Tait Wojno; Thomas C Fung; Masato Kubo; David Artis
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

2.  Histamine H1, H3 and H4 receptors are involved in pruritus.

Authors:  K Rossbach; C Nassenstein; M Gschwandtner; D Schnell; K Sander; R Seifert; H Stark; M Kietzmann; W Bäumer
Journal:  Neuroscience       Date:  2011-06-13       Impact factor: 3.590

3.  Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.

Authors:  T Hawro; R Saluja; K Weller; S Altrichter; M Metz; M Maurer
Journal:  Allergy       Date:  2013-11-20       Impact factor: 13.146

Review 4.  Epithelial Cell Regulation of Allergic Diseases.

Authors:  Naina Gour; Stephane Lajoie
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

5.  Increased number of immunoreactive nerve fibers in atopic dermatitis.

Authors:  D Tobin; G Nabarro; H Baart de la Faille; W A van Vloten; S C van der Putte; H J Schuurman
Journal:  J Allergy Clin Immunol       Date:  1992-10       Impact factor: 10.793

6.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Authors:  Lisa A Beck; Diamant Thaçi; Jennifer D Hamilton; Neil M Graham; Thomas Bieber; Ross Rocklin; Jeffrey E Ming; Haobo Ren; Richard Kao; Eric Simpson; Marius Ardeleanu; Steven P Weinstein; Gianluca Pirozzi; Emma Guttman-Yassky; Mayte Suárez-Fariñas; Melissa D Hager; Neil Stahl; George D Yancopoulos; Allen R Radin
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

7.  Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.

Authors:  Yasutomo Imai; Koubun Yasuda; Yoshiko Sakaguchi; Takashi Haneda; Hitoshi Mizutani; Tomohiro Yoshimoto; Kenji Nakanishi; Kiyofumi Yamanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

8.  Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice.

Authors:  J K Bell; D S McQueen; J L Rees
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

Review 9.  The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study.

Authors:  Yusuke Ohsawa; Noriyasu Hirasawa
Journal:  Allergol Int       Date:  2014-12       Impact factor: 5.836

Review 10.  Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.

Authors:  Corinne Cayrol; Jean-Philippe Girard
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more
  18 in total

Review 1.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 2.  Perfect timing: circadian rhythms, sleep, and immunity - an NIH workshop summary.

Authors:  Jeffrey A Haspel; Ron Anafi; Marishka K Brown; Nicolas Cermakian; Christopher Depner; Paula Desplats; Andrew E Gelman; Monika Haack; Sanja Jelic; Brian S Kim; Aaron D Laposky; Yvonne C Lee; Emmanuel Mongodin; Aric A Prather; Brian J Prendergast; Colin Reardon; Albert C Shaw; Shaon Sengupta; Éva Szentirmai; Mahesh Thakkar; Wendy E Walker; Laura A Solt
Journal:  JCI Insight       Date:  2020-01-16

Review 3.  The Neuroimmune Axis in Skin Sensation, Inflammation, and Immunity.

Authors:  Anna M Trier; Madison R Mack; Brian S Kim
Journal:  J Immunol       Date:  2019-05-15       Impact factor: 5.422

4.  Kallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation.

Authors:  Changxiong J Guo; Madison R Mack; Landon K Oetjen; Anna M Trier; Martha L Council; Ana B Pavel; Emma Guttman-Yassky; Brian S Kim; Qin Liu
Journal:  J Invest Dermatol       Date:  2019-12-26       Impact factor: 8.551

5.  The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype.

Authors:  Donald Y M Leung; Agustin Calatroni; Livia S Zaramela; Petra K LeBeau; Nathan Dyjack; Kanwaljit Brar; Gloria David; Keli Johnson; Susan Leung; Marco Ramirez-Gama; Bo Liang; Cydney Rios; Michael T Montgomery; Brittany N Richers; Clifton F Hall; Kathryn A Norquest; John Jung; Irina Bronova; Simion Kreimer; C Conover Talbot; Debra Crumrine; Robert N Cole; Peter Elias; Karsten Zengler; Max A Seibold; Evgeny Berdyshev; Elena Goleva
Journal:  Sci Transl Med       Date:  2019-02-20       Impact factor: 17.956

Review 6.  The Itch-Scratch Cycle: A Neuroimmune Perspective.

Authors:  Madison R Mack; Brian S Kim
Journal:  Trends Immunol       Date:  2018-11-21       Impact factor: 16.687

Review 7.  Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.

Authors:  Fatima Bawany; Carrie A Northcott; Lisa A Beck; Wilfred R Pigeon
Journal:  J Allergy Clin Immunol Pract       Date:  2020-12-13

8.  Chronic Pruritus Responding to Dupilumab-A Case Series.

Authors:  Lisa L Zhai; Kevin T Savage; Connie C Qiu; Annie Jin; Rodrigo Valdes-Rodriguez; Nicholas K Mollanazar
Journal:  Medicines (Basel)       Date:  2019-06-29

9.  Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.

Authors:  Emma Guttman-Yassky; Andrew Blauvelt; Lawrence F Eichenfield; Amy S Paller; April W Armstrong; Janice Drew; Ramanan Gopalan; Eric L Simpson
Journal:  JAMA Dermatol       Date:  2020-04-01       Impact factor: 10.282

Review 10.  Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.

Authors:  Matthew Moyle; Ferda Cevikbas; Jamie L Harden; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2019-04-15       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.